Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am. 2012;38:441–76. https://doi.org/10.1016/j.rdc.2012.09.003.
Article PubMed PubMed Central Google Scholar
Generali E, Bose T, Selmi C, Voncken JW, Damoiseaux JGMC. Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory. Autoimmun Rev. 2018;17:935–41. https://doi.org/10.1016/j.autrev.2018.04.002.
CAS Article PubMed Google Scholar
Khan MA. Editorial overview: Spondyloarthropathies. Curr Opin Rheumatol. 1998;10:279–81.
Tanaka H, Akaza T, Juji T. Report of the Japanese central bone marrow data center. Clin Transpl. 1996;139–44
Yamaguchi A, Tsuchiya N, Mitsui H, Shiota M, Ogawa A, Tokunaga K, et al. Association of Hla-B39 with Hla-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum. 1995;38:1672–7. https://doi.org/10.1002/art.1780381120.
CAS Article PubMed Google Scholar
Tsuchiya N, Shiota M, Moriyama S, Ogawa A, Komatsu-Wakui M, Mitsui H, et al. MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypes. Arthritis Rheum. 1998;41:68–73. https://doi.org/10.1002/1529-0131(199801)41:1%3c68::AID-ART9%3e3.0.CO;2-C.
CAS Article PubMed Google Scholar
Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004;63:535–43. https://doi.org/10.1136/ard.2003.011247.
CAS Article PubMed PubMed Central Google Scholar
Baraliakos X, Braun J. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD Open. 2015;1(Suppl 1): e000053. https://doi.org/10.1136/rmdopen-2015-000053.
CAS Article PubMed PubMed Central Google Scholar
Bohn R, Cooney M, Deodhar A, Curtis JR, Golembesky A. Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature. Clin Exp Rheumatol. 2018;36:263–74.
• Bittar M, Yong WC, Magrey M, Khan MA. Worldwide differences in clinical phenotype of axial spondyloarthritis. Curr Rheumatol Rep. 2021;23:76. https://doi.org/10.1007/s11926-021-01043-5. This review describes variations in the clinical presentation of axSpA across the world.
Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001;28:554–9.
Khan MA, van der Linden SM, Kushner I, Valkenburg HA, Cats A. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985;28:40–3. https://doi.org/10.1002/art.1780280107.
CAS Article PubMed Google Scholar
• Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, et al. Clinical characteristics of patients with spondyloarthritis in Japan in comparison with other regions of the world. J Rheumatol. 2019;46:896–903. https://doi.org/10.3899/jrheum.180412. This study elucidated clinical characteristics of patients with SpA in Japan compared to that in other areas of the world.
Boel A, Molto A, van der Heijde D, Ciurea A, Dougados M, Gensler LS, et al. Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. Ann Rheum Dis. 2019;78:1545–9. https://doi.org/10.1136/annrheumdis-2019-215707.
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777–83. https://doi.org/10.1136/ard.2009.108233.
CAS Article PubMed Google Scholar
Kishimoto M, Ono K, Fukui S, Kawaai S, Deshpande GA, Yoshida K, et al. Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study. RMD Open. 2021;7:e001752.
•• Matsubara Y, Nakamura Y, Tamura N, Kameda H, Otomo K, Kishimoto M, et al. A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan. Mod Rheumatol. 2021. https://doi.org/10.1093/mr/roab096. This is a recent nationwide survey of SpA conducted in 2,221 randomly selected medical facilities in Japan.
Nakashima Y, Ohishi M, Okazaki K, Fukushi J, Oyamada A, Hara D, et al. Delayed diagnosis of ankylosing spondylitis in a Japanese population. Mod Rheumatol. 2016;26:421–5. https://doi.org/10.3109/14397595.2015.1088679.
López-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A. Characteristics and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5: e001108. https://doi.org/10.1136/rmdopen-2019-001108.
Article PubMed PubMed Central Google Scholar
Endo Y, Fujikawa K, Koga T, Mizokami A, Mine M, Tsukada T, et al. Characteristics of late-onset spondyloarthritis in Japan: a retrospective cohort study. Medicine. 2019;98: e14431. https://doi.org/10.1097/MD.0000000000014431.
CAS Article PubMed PubMed Central Google Scholar
Sugihara T, Ishizaki T, Onoguchi W, Baba H, Matsumoto T, Iga S, et al. Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study. Rheumatology (Oxford). 2021;60:4252–61. https://doi.org/10.1093/rheumatology/keaa922.
Tomita T, Sato M, Esterberg E, Parikh RC, Hagimori K, Nakajo K. Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: a hospital claims database analysis. Mod Rheumatol. 2021;31:431–41. https://doi.org/10.1080/14397595.2020.1775927.
Inui K, Sato M, Esterberg E, Parikh RC, Kimura S, Torisu-Itakura H. Treatment practices and costs among patients with psoriatic arthritis: a Japanese hospital claims database analysis. Mod Rheumatol. 2021;31:1179–91. https://doi.org/10.1080/14397595.2021.1886629.
CAS Article PubMed Google Scholar
Braun J, Baraliakos X, Kiltz U, Heldmann F, Sieper J. Classification and diagnosis of axial spondyloarthritis – what is the clinically relevant difference? J Rheumatol. 2015;42:31–8. https://doi.org/10.3899/jrheum.130959.
Deodhar A, Strand V, Kay J, Braun J. The term “non-radiographic axial spondyloarthritis” is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis. 2016;75:791–4. https://doi.org/10.1136/annrheumdis-2015-208852.
CAS Article PubMed Google Scholar
Ohara Y, Kishimoto M, Takizawa N, Yoshida K, Okada M, Eto H, et al. Prevalence and clinical characteristics of psoriatic arthritis in Japan. J Rheumatol. 2015;42:1439–42. https://doi.org/10.3899/jrheum.141598.
CAS Article PubMed Google Scholar
Kamo K, Shuto T, Haraguchi A. Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: a questionnaire survey. Mod Rheumatol. 2015;25:435–7. https://doi.org/10.3109/14397595.2014.964925.
CAS Article PubMed Google Scholar
•• Kameda H, Kobayashi S, Tamura N, Kadono Y, Tada K, Yamamura M, et al. Non-radiographic axial spondyloarthritis. Mod Rheumatol. 2021;31:277–82. https://doi.org/10.1080/14397595.2020.1830512. This review introduced diagnostic guidance for nr-axSpA in Japan.
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum. 1984;27:361–8. https://doi.org/10.1002/art.1780270401
Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of spondyloarthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68;Suppl 2:ii1–44. https://doi.org/10.1136/ard.2008.104018
Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977;237:2613–4.
Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006;54:569–78. https://doi.org/10.1002/art.21619.
Lambert RGW, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis. 2016;75:1958–63. https://doi.org/10.1136/annrheumdis-2015-208642.
Kobayashi S, Yoshinari T. A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis. Mod Rheumatol. 2017;27:142–9. https://doi.org/10.1080/14397595.2016.1176635.
CAS Article PubMed Google Scholar
Kobayashi S, Harigai M, Mozaffarian N, Pangan AL, Sharma S, Brown LS, et al. A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis. Mod Rheumatol. 2012;22:589–97. https://doi.org/10.1007/s10165-011-0557-x.
CAS Article PubMed Google Scholar
Miyasaka N, CHANGE Study Investigators. Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study. Mod Rheumatol. 2008;18:252–62. https://doi.org/10.1007/s10165-008-0045-0
Kobayashi S, Kashiwagi T, Kimura J. Real-world effectiveness and safety of adalimumab for treatment of ankylosing spondylitis in Japan. Mod Rheumatol. 2019;29:1007–12. https://doi.org/10.1080/14397595.2018.1525024.
CAS Article PubMed Google Scholar
Kishimoto M, Taniguchi A, Fujishige A, Kaneko S, Haemmerle S, Porter BO, et al. Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J). Mod Rheumatol. 2020;30:132–40. https://doi.org/10.1080/14397595.2018.1538004.
CAS Article PubMed Google Scholar
Machado PM, Landewé R, van der Heijde DV, Assessment of SpondyloArthritis international Society (ASAS). Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis. 2018;77:1539–40. https://doi.org/10.1136/annrheumdis-2018-213184
Makino T, Ihn H, Nakagawa M, Urano M, Okuyama R, Katoh N, et al. Effect of adalimumab on axial manifestations in Japanese patients with psoriatic arthritis: a 24 week prospective, observational study. Rheumatology (Oxford). 2021;60:3669–78. https://doi.org/10.1093/rheumatology/keaa829.
Fujita H, Ohtsuki M, Morita A, Nagao R, Seko N, Matsumoto K, et al. Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: real-world evidence in Japan. J Dermatol. 2021;48:175–83. https://doi.org/10.1111/1346-8138.15655.
CAS Article PubMed Google Scholar
Braun J, Landewé RB. No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’? Ann Rheum Dis. 2021. https://doi.org/10.1136/annrheumdis-2021-221422.
Yamamoto T, Kawada A. Clinical characteristics of Japanese patients with psoriatic arthritis: comparison with East Asian countries. J Dermatol. 2018;45:273–8. https://doi.org/10.1111/1346-8138.14097.
Nakagawa H, Tanaka Y, Sano S, Kameda H, Taniguchi A, Kashiwagi T, et al. Real-world postmarketing study of the impact of adalimumab treatment on work productivity and activity impairment in patients with psoriatic arthritis. Adv Ther. 2019;36:691–707. https://doi.org/10.1007/s12325-018-0866-y.
留言 (0)